
Genre Early AccessReleased Oct 5, 2024
The Killing Antidote
Developed and published by MetalStar Studio
$29.99
Estimated lifetime revenue
$3.05M
Gross, before Steam's cut
Net revenue
$2.14M
After Steam's 30% cut
Units sold
160.8K
≈ 20 sales per review
Reviews
8,057
Very Positive87% positive
Playing now
198
3-day peak 198 · low 135
New reviews, last 3 days
+16
≈ 5 a day since Nov 12
History
Nov 12 – Nov 15
8.1K8.1K8.0K8.0K
Nov 12Nov 13Nov 15
Total Steam reviews. The slope is the signal: a steady climb long after launch means the game is still selling.
How it compares
Early Access →Against the 140 most-reviewed Early Access games on Steam
Outearns 34% of them — below the group's median.
Median
$4.90M
26,277 reviews
Top 10% start at
$44.68M
This game
$3.05M
Fewest reviews of the group
The group is the games with the most reviews under this tag, not every release, so it leans toward games that sold — a percentile here is a harder test than the same percentile across the whole store would be.
About
This is a TPS game. Shooting, fighting, dress-up, puzzle solving, and more. In the future, a special germ causes humans to be constantly infected and mutated. The protagonist, Jodi, is a brave journalist who goes on her way to find the legendary antidote and is in danger.
- Developer
- MetalStar Studio
- Publisher
- MetalStar Studio
- Genre
- Early Access
- Released
- Oct 5, 2024
- Steam app ID
- 2254890
- Data updated
- Nov 15, 2026
Estimates, not reported sales. No developer-published figures are on file for this game. See the methodology for how the numbers are built.